Study of BZ371A for women with sexual arousal disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests an investigational medication, BZ371A, to see if it can help women with Female Sexual Arousal Disorder (FSAD), a condition where they have trouble getting or keeping physical signs of arousal like lubrication and warmth. The study aims to find out if BZ371A is safe, effective, and well-tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 21 and 60 years old.
- You have been diagnosed with Female Sexual Arousal Disorder (FSAD), meaning you often struggle to get or maintain physical arousal during sex.
- You have been in a stable relationship with a sexually active partner for at least 6 months.
- You agree to try having sex at least twice a week while taking the study medication.
- You are willing to use birth control if you could become pregnant, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, BZ371A, to see if it can safely improve sexual arousal in women who have a hard time getting or keeping physical signs of arousal like lubrication or clitoral swelling. It is designed for women in a stable relationship who have had previous sexual experiences but now struggle with arousal, and who find this distressing.
This study tests a device that uses gentle electrical stimulation to improve sexual function in women. You can use it at home after being trained at the study center.
This study tests an experimental oral medication, S1B-408, to see if it improves orgasm function in women with orgasmic disorder. It may be a good option if you have trouble achieving orgasm and are looking for a potential new treatment.
This study tests whether a medication called bupropion can help women with hormone receptor-positive breast cancer who are taking aromatase inhibitors (drugs that block estrogen) but experiencing low sexual desire as a side effect. The goal is to see if this approach improves both tolerance to the cancer medication and quality of life.
This study tests an experimental vaginal cream (AZU-101) for postmenopausal women who have vaginal dryness and pain during sex. The goal is to see if it can improve these symptoms without the risks of hormone treatments.
This Phase 1 trial tests how an IV medicine called ZMA001 behaves in healthy people and checks for early safety. It may help future studies of the drug by confirming dosing and effects in people before testing in patients.
Hear when a new Female Sexual Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.